The Superior Vena Cava Syndrome: A Review of the History and the Present Prospects of Target TherapyWilson I. B. Onuigbo*
Medical Foundation & Clinic, 8 Nsukka Lane, Box 1792, Enugu 400001, Nigeria
- *Corresponding Author:
- Wilson Onuigbo
Medical Foundation & Clinic
8 Nsukka Lane, Box 1792
Enugu 400001, Nigeria
E-mail: [email protected]
Received date: September 02, 2014; Accepted date: February 27, 2015; Published date: March 03, 2015
Citation: Onuigbo WIB (2015) The Superior Vena Cava Syndrome: A Review of the History and the Present Prospects of Target Therapy. J Pulm Respir Med 5:244. doi:10.4172/2161-105X.1000244
Copyright: © 2015 Onuigbo WIB, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Method: The present paper deals with the history of the syndrome from 1833 to 1892 with reference to lung cancer.
Results: The old authorities provided such detailed data that lines for future research are derivable. Thus, much as expectations from the theory of lung cancer spread are those of superabundant secondaries, the reality is that particular cases exhibit secondaries which are merely adjacent to the main tumor.
Conclusion: It is hypothesized that, as this is Nature’s own model, translational laboratories should explore employing it as a human model.